CROs Under Fire

This article on Bio Health Investor discusses how although CROs experienced rapid growth up until August this year, it seems as if the trend is coming to a crashing halt. Apparently CROs are not immune to the global economic crisis; Charles River Laboratories have even reported that it is cutting its guidance for 2008.

Now there is even a concern for the amount of jobs that will be available in the CRO sector. CRO stocks have been performing horrible as of lately. Time will only tell what the future lies in store for the medical industry.